Ste 380
Palo Alto, CA 94304
Facsímil: (650) 721-2884
My approach to medical care is to listen to each individual story from both the child and the family, engage them in open discussion, and provide them with evidence-based medicine to empower them to navigate their health care decisions. Open and ongoing communication with children and their families is fundamental, as well as a team-based approach with all health care providers involved in the care of the child. The child and the family are the most important players on our team!
I am proud to be able to build long-lasting relationships with children and their families. Nothing gives me more joy than seeing a smile on a child’s face at the end of his or her appointment.
I became a physician because of the many roles I have and enjoy doing. People may view physicians as only medical experts, but other fun parts of being a physician are being a teacher, a constant learner as medicine is ever-changing, a collaborator, a scholar, and a health advocate for my patients and families. I chose to specialize in pediatric pulmonology because the intricacies in the way our lungs function fascinate me.
Boston University School of Medicine, Boston, MA, 06/01/2008
UCSF Benioff Childrens Hospital Pediatric Residency, Oakland, CA, 06/30/2011
UCSF Benioff Childrens Hospital Pediatric Pulmonary Fellowship, Oakland, CA, United States of America, 06/30/2015
Pediatric Pulmonary, American Board of Pediatrics
Pediatrics, American Board of Pediatrics
View details for Web of Science ID 000921450900590
The following is a concise review of the Pediatric Pulmonary Medicine Core reviewing pediatric pulmonary infections, diagnostic assays, and imaging techniques presented at the 2021 American Thoracic Society Core Curriculum. Molecular methods have revolutionized microbiology. We highlight the need to collect appropriate samples for detection of specific pathogens or for panels and understand the limitations of the assays. Considerable progress has been made in imaging modalities for detecting pediatric pulmonary infections. Specifically, lung ultrasound and lung magnetic resonance imaging are promising radiation-free diagnostic tools, with results comparable with their radiation-exposing counterparts, for the evaluation and management of pulmonary infections. Clinicians caring for children with pulmonary disease should ensure that patients at risk for nontuberculous mycobacteria disease are identified and receive appropriate nontuberculous mycobacteria screening, monitoring, and treatment. Children with coronavirus disease (COVID-19) typically present with mild symptoms, but some may develop severe disease. Treatment is mainly supportive care, and most patients make a full recovery. Anticipatory guidance and appropriate counseling from pediatricians on social distancing and diagnostic testing remain vital to curbing the pandemic. The pediatric immunocompromised patient is at risk for invasive and opportunistic pulmonary infections. Prompt recognition of predisposing risk factors, combined with knowledge of clinical characteristics of microbial pathogens, can assist in the diagnosis and treatment of specific bacterial, viral, or fungal diseases.
View details for DOI 10.34197/ats-scholar.2021-0034RE
View details for PubMedID 34667993
View details for DOI 10.1002/ppul.24267
View details for Web of Science ID 000468315500016